Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06442475
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-05-29
Brief Title:
Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma
Sponsor:
University of Washington
Organization:
University of Washington
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Grade 3a Follicular Lymphoma |
| Ann Arbor Stage II Follicular Lymphoma |
| Ann Arbor Stage II Marginal Zone Lymphoma |
| Ann Arbor Stage III Follicular Lymphoma |
| Ann Arbor Stage III Marginal Zone Lymphoma |
| Ann Arbor Stage IV Follicular Lymphoma |
| Ann Arbor Stage IV Marginal Zone Lymphoma |
| Grade 1 Follicular Lymphoma |
| Grade 2 Follicular Lymphoma |
Keywords: